General

Cricketer-turned-Politician Navjot Singh Sidhu to formally launch Today new political front “Awaaz-e-Punjab” in Chandigarh

Author : NewsGram Desk

CHANDIGARH: Sept 08, 2016: Cricketer-turned-politician Navjot Singh Sidhu will formally announce a new political front 'Awaaz-e-Punjab' today, in Chandigarh today.

The former Rajya Sabha member had on September 2 floated the new political front online. It will contest the Punjab assembly elections, slated for early next year.

Other members of the new front include former Indian hockey team captain Pargat Singh, a legislator of Punjab's ruling Shiromani Akali Dal, and two independent legislators, Balwinder Singh Bains and Simarjeet Singh Bains.

Follow NewsGram on Twitter

"A press conference will be addressed by Sidhu on Thursday along with Pargat Singh and Bains brothers," Simarjeet Bains said here on Wednesday.

With the formal launch of the new political outfit, Sidhu is likely to put an end to all speculation of his joining the Aam Aadmi Party (AAP).

Pargat Singh was last month suspended from the Akali Dal for "anti-party" activities.

Follow NewsGram on Facebook

Sidhu had resigned from the Rajya Sabha on July 18, fuelling speculation that he may join the AAP.

The Bains brothers, who had fallen out with the Akali Dal top leadership three years ago, have significant influence in Ludhiana district.

Elections to 117 assembly seats are likely to be held in January or early February next year. (IANS)

Subscribe to our channels on YouTube and WhatsApp 

‘This Is a Death Sentence for Us’: Unnao Rape Survivor Reacts After Delhi High Court Grants Bail To Kuldeep Singh Sengar

Trump Sinks Deeper Into the Epstein Files as FBI Reports Emerge Alleging Rape of a Female Victim

Brother of Slain Activist Accuses Yunus-Led Interim Govt of ‘Plotting Murder’ of Osman Hadi to Sabotage 2026 Bangladesh Polls, Calls for Speedy Trial

A Renowned Indian Writer And The Winner Of Jnanpith Award - Vinod Kumar Shukla, Passes Away At 88

Hope Against Deadly Nipah Virus: Phase 1 Trial Finds New Vaccine Safe and Immunogenic